Harbour Investments Inc. Has $806,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Harbour Investments Inc. grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,544 shares of the medical equipment provider’s stock after purchasing an additional 32 shares during the quarter. Harbour Investments Inc.’s holdings in Intuitive Surgical were worth $806,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. bought a new position in Intuitive Surgical during the 4th quarter worth approximately $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at $82,517,000. Sycomore Asset Management increased its stake in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares in the last quarter. Exome Asset Management LLC increased its stake in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its stake in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after acquiring an additional 525 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Piper Sandler reissued an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Citigroup lifted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. CICC Research assumed coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target for the company. Finally, Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $492.06 on Thursday. The company’s 50-day moving average is $564.39 and its 200 day moving average is $531.62. The company has a market capitalization of $175.26 billion, a P/E ratio of 76.76, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.